BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
ACV Auctions
ACVA
$1.35B
| $16.8M | ﹤0.01% |
938,809
+389,717
| +71% | +$8.27M |
|
|
AGS
3377
DELISTED
PlayAGS
AGS
| $16.8M | ﹤0.01% |
2,130,671
+60,655
| +3% | +$482K |
|
3378
Aterian
ATER
$5.26M
| $16.8M | ﹤0.01% |
128,990
+25,545
| +25% | +$2.83M |
|
3379
Descartes Systems
DSGX
$6.62B
| $16.7M | ﹤0.01% |
206,003
+15,470
| +8% | +$1.17M |
|
|
VIRX
3380
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $16.7M | ﹤0.01% |
2,085,048
+23,877
| +1% | +$235K |
|
|
EMBJ
3381
Embraer S.A. ADS
EMBJ
$13.2B
| $16.7M | ﹤0.01% |
982,817
+588,963
| +150% | +$9.15M |
|
|
DOMA
3382
DELISTED
Doma Holdings, Inc.
DOMA
| $16.7M | ﹤0.01% |
+90,320
| New | +$18.9M |
|
3383
Coastal Financial
CCB
$754M
| $16.7M | ﹤0.01% |
523,052
+29,431
| +6% | +$877K |
|
|
LBC
3384
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $16.7M | ﹤0.01% |
1,242,010
+10,752
| +0.9% | +$137K |
|
3385
The Honest Company
HNST
$540M
| $16.7M | ﹤0.01% |
1,604,587
-5,011,560
| -76% | -$61.2M |
|
|
PLYA
3386
DELISTED
Playa Hotels & Resorts
PLYA
| $16.6M | ﹤0.01% |
2,004,006
+21,539
| +1% | +$153K |
|
3387
Eterna Therapeutics
ERNA
$5.16M
| $16.6M | ﹤0.01% |
238
+51
| +27% | +$4.4M |
|
3388
iShares Core Conservative Allocation ETF
AOK
$795M
| $16.6M | ﹤0.01% |
420,473
-12,628
| -3% | -$506K |
|
3389
Safe Bulkers
SB
$760M
| $16.6M | ﹤0.01% |
3,211,652
+351,790
| +12% | +$1.36M |
|
3390
Citius Pharmaceuticals
CTXR
$20.1M
| $16.6M | ﹤0.01% |
326,322
+1,341
| +0.4% | +$67.3K |
|
3391
Evolus
EOLS
$536M
| $16.6M | ﹤0.01% |
2,172,390
+45,024
| +2% | +$466K |
|
|
EIGR
3392
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $16.5M | ﹤0.01% |
82,471
-66
| -0.1% | -$15.7K |
|
3393
PUT
Seagate
STX
$209B
| $16.5M | ﹤0.01% |
+200,000
| New | +$17.4M |
|
3394
iBio
IBIO
$73M
| $16.4M | ﹤0.01% |
31,034
-73
| -0.2% | -$45.5K |
|
3395
Tonix Pharmaceuticals
TNXP
$214M
| $16.4M | ﹤0.01% |
43
+2
| +5% | +$974K |
|
3396
Home Bancorp
HBCP
$567M
| $16.4M | ﹤0.01% |
423,412
-35,317
| -8% | -$1.31M |
|
3397
Superior Group of Companies
SGC
$213M
| $16.4M | ﹤0.01% |
702,402
-5,912
| -0.8% | -$139K |
|
3398
Century Therapeutics
IPSC
$355M
| $16.3M | ﹤0.01% |
+648,656
| New | +$17.6M |
|
3399
AB InBev
BUD
$158B
| $16.3M | ﹤0.01% |
289,183
+2,418
| +0.8% | +$152K |
|
3400
Hims & Hers Health
HIMS
$6.71B
| $16.2M | ﹤0.01% |
2,151,909
+833,033
| +63% | +$7.06M |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.